PET of somatostatin receptor-positive tumors using 64Cu- and 68Ga-somatostatin antagonists: the chelate makes the difference

Somatostatin-based radiolabeled peptides have been successfully introduced into the clinic for targeted imaging and radionuclide therapy of somatostatin receptor (sst)-positive tumors, especially of subtype 2 (sst2). The clinically used peptides are exclusively agonists. Recently, we showed that radiolabeled antagonists may be preferable to agonists because they showed better pharmacokinetics, including higher tumor uptake. Factors determining the performance of radioantagonists have only scarcely been studied. Here, we report on the development and evaluation of four (64)Cu or (68)Ga radioantagonists for PET of sst2-positive tumors.

Making a Difference Beyond the Workplace

Library and IT staff volunteer their time outside of work to many charitable organizations.

Efficient implementation of discrete Pascal transform using difference operators

An alternative way is provided to define the discrete Pascal transform using difference operators to reveal the fundamental concept of the transform, in both one- and two-dimensional cases, which is extended to cover non-square two-dimensional applications. Efficient modularised implementations are proposed.